A phase 3, randomized, open-label trial comparing trastuzumab emtansine and trastuzumab as adjuvant therapy for HER2-positive primary breast cancer with residual invasive tumor in the breast or axillary lymph nodes following preoperative therapy (KATHERINE)

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorGEYER, C. E.
dc.contributor.authorLOIBL, S.
dc.contributor.authorMAMOUNAS, E. P.
dc.contributor.authorUNTCH, M.
dc.contributor.authorWOLMARK, N.
dc.contributor.authorHUANG, C-S
dc.contributor.authorMANO, M.
dc.contributor.authorZHENG, M.
dc.contributor.authorSMITT, M.
dc.contributor.authorMINCKWITZ, G. von
dc.date.accessioned2016-11-22T14:22:53Z
dc.date.available2016-11-22T14:22:53Z
dc.date.issued2013
dc.description.indexMEDLINE
dc.identifier.citationCANCER RESEARCH, v.73, suppl.24, 2013
dc.identifier.doi10.1158/0008-5472.SABCS13-OT1-1-06
dc.identifier.eissn1538-7445
dc.identifier.issn0008-5472
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/16651
dc.language.isoeng
dc.publisherAMER ASSOC CANCER RESEARCH
dc.relation.ispartofCancer Research
dc.rightsrestrictedAccess
dc.rights.holderCopyright AMER ASSOC CANCER RESEARCH
dc.subject.wosOncology
dc.titleA phase 3, randomized, open-label trial comparing trastuzumab emtansine and trastuzumab as adjuvant therapy for HER2-positive primary breast cancer with residual invasive tumor in the breast or axillary lymph nodes following preoperative therapy (KATHERINE)
dc.typeconferenceObject
dc.type.categorymeeting abstract
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.contributor.author-fmusphcMAX SENNA MANO
hcfmusp.description.issuesuppl 24
hcfmusp.description.volume73
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000209496900037
hcfmusp.publisher.cityPHILADELPHIA
hcfmusp.publisher.countryUSA
relation.isAuthorOfPublication1541ce2f-dafd-4094-b650-ef95fa7da1e3
relation.isAuthorOfPublication.latestForDiscovery1541ce2f-dafd-4094-b650-ef95fa7da1e3
Arquivos
Coleções
Comunicações em Eventos - FM/MDR
Comunicações em Eventos - LIM/24